Dana S. Wollins, DrPH, MGC
Vice President, Clinical Affairs & Practice Guidelines, IDSA
Update on Avian Influenza
Tim Uyeki, MD, MPH, MPP
Chief Medical Officer, Influenza Division
U.S. Centers for Disease Control and Prevention
Update on authorization changes to simplify use of bivalent mRNA COVID-19 vaccines and review of how each vaccine product will be affected by these changes.
Peter Marks, MD, PhD
Director, Center for Biologics Evaluation and Research
U.S. Food and Drug Administration
Recap of data recently presented at ACIP on bivalent safety and effectiveness, and review of new recommendations for the general population, older adults and immunocompromised adults.
Sara Oliver, MD, MSPH
LCDR, U.S. Public Health Service
Co-Lead, COVID-19 Work Group of the Advisory Committee on Immunization Practices
U.S. Centers for Disease Control and Prevention (ACIP)